Soleno Therapeutics Stock Last Dividend Paid

SLNO Stock  USD 47.09  0.26  0.55%   
Soleno Therapeutics fundamentals help investors to digest information that contributes to Soleno Therapeutics' financial success or failures. It also enables traders to predict the movement of Soleno Stock. The fundamental analysis module provides a way to measure Soleno Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Soleno Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Soleno Therapeutics Company Last Dividend Paid Analysis

Soleno Therapeutics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

 = 

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Soleno Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Soleno Therapeutics is extremely important. It helps to project a fair market value of Soleno Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Soleno Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Soleno Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Soleno Therapeutics' interrelated accounts and indicators.
0.980.51-0.99-0.810.57-0.49-0.180.99-0.410.360.120.25-0.070.59-0.52-0.90.410.950.970.11-0.9
0.980.65-0.98-0.840.6-0.54-0.360.97-0.560.410.110.350.070.64-0.65-0.860.460.910.930.11-0.86
0.510.65-0.53-0.730.69-0.67-0.830.45-0.990.610.140.630.390.73-0.82-0.310.630.310.350.24-0.31
-0.99-0.98-0.530.8-0.570.450.2-0.990.43-0.34-0.13-0.230.02-0.580.530.89-0.34-0.96-0.97-0.090.89
-0.81-0.84-0.730.8-0.810.760.35-0.770.63-0.58-0.39-0.42-0.01-0.90.750.62-0.58-0.63-0.68-0.210.62
0.570.60.69-0.57-0.81-0.74-0.250.52-0.60.860.430.62-0.050.9-0.62-0.260.540.360.410.64-0.26
-0.49-0.54-0.670.450.76-0.740.34-0.390.63-0.69-0.17-0.640.11-0.910.630.15-0.91-0.2-0.26-0.320.15
-0.18-0.36-0.830.20.35-0.250.34-0.130.87-0.32-0.01-0.53-0.75-0.350.780.11-0.38-0.07-0.07-0.040.11
0.990.970.45-0.99-0.770.52-0.39-0.13-0.340.290.130.18-0.060.52-0.48-0.930.290.980.990.07-0.93
-0.41-0.56-0.990.430.63-0.60.630.87-0.34-0.56-0.07-0.6-0.42-0.650.770.21-0.62-0.21-0.24-0.20.21
0.360.410.61-0.34-0.580.86-0.69-0.320.29-0.560.360.770.040.73-0.58-0.10.640.140.180.87-0.1
0.120.110.14-0.13-0.390.43-0.17-0.010.13-0.070.36-0.090.00.37-0.3-0.09-0.050.070.090.36-0.09
0.250.350.63-0.23-0.420.62-0.64-0.530.18-0.60.77-0.090.250.63-0.690.020.660.060.080.590.02
-0.070.070.390.02-0.01-0.050.11-0.75-0.06-0.420.040.00.250.0-0.560.04-0.13-0.04-0.05-0.060.04
0.590.640.73-0.58-0.90.9-0.91-0.350.52-0.650.730.370.630.0-0.75-0.260.710.350.40.37-0.26
-0.52-0.65-0.820.530.75-0.620.630.78-0.480.77-0.58-0.3-0.69-0.56-0.750.35-0.52-0.37-0.4-0.240.35
-0.9-0.86-0.310.890.62-0.260.150.11-0.930.21-0.1-0.090.020.04-0.260.35-0.14-0.94-0.940.061.0
0.410.460.63-0.34-0.580.54-0.91-0.380.29-0.620.64-0.050.66-0.130.71-0.52-0.140.120.170.31-0.14
0.950.910.31-0.96-0.630.36-0.2-0.070.98-0.210.140.070.06-0.040.35-0.37-0.940.121.0-0.01-0.94
0.970.930.35-0.97-0.680.41-0.26-0.070.99-0.240.180.090.08-0.050.4-0.4-0.940.171.00.01-0.94
0.110.110.24-0.09-0.210.64-0.32-0.040.07-0.20.870.360.59-0.060.37-0.240.060.31-0.010.010.06
-0.9-0.86-0.310.890.62-0.260.150.11-0.930.21-0.1-0.090.020.04-0.260.351.0-0.14-0.94-0.940.06
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition

Based on the recorded statements, Soleno Therapeutics has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Soleno Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Soleno Therapeutics from analyzing Soleno Therapeutics' financial statements. These drivers represent accounts that assess Soleno Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Soleno Therapeutics' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap100.4M120.9M32.7M16.6M15.0M14.2M
Enterprise Value80.0M71.8M11.9M2.2M2.0M1.9M

Soleno Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Soleno Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Soleno Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Soleno Fundamentals

About Soleno Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Soleno Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Soleno Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Soleno Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Soleno Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Soleno Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Soleno Stock

  0.48MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.35LLY Eli LillyPairCorr
The ability to find closely correlated positions to Soleno Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Soleno Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Soleno Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Soleno Therapeutics to buy it.
The correlation of Soleno Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Soleno Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Soleno Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Soleno Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Soleno Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soleno Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soleno Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soleno Therapeutics Stock:
Check out Soleno Therapeutics Piotroski F Score and Soleno Therapeutics Altman Z Score analysis.
To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.79)
Return On Assets
(0.48)
Return On Equity
(0.91)
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.